Related Experiment Videos
Squamous cell carcinoma of the bladder
The Journal of Urology
|May 1, 1976
Summary
Squamous cell carcinoma of the bladder is aggressive, with low survival rates. Combination therapy, including preoperative radiotherapy and cystectomy, shows promising survival rates exceeding 34% for advanced bladder cancer.
Area of Science:
- Uro-oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Squamous cell carcinoma (SCC) of the bladder is an aggressive malignancy.
- This study reviews clinical and morphological features of 90 bladder SCC cases.
Purpose of the Study:
- To analyze the characteristics of bladder SCC.
- To evaluate treatment outcomes and survival rates.
- To explore the efficacy of combination therapy for advanced bladder cancer.
Main Methods:
- Retrospective review of 90 patients with squamous cell carcinoma of the bladder.
- Analysis of clinical presentation, staging, and treatment modalities.
- Comparison of survival rates between different treatment approaches.
Main Results:
- All diagnosed lesions were invasive; 42% presented with ureteral obstruction.
- Overall 5-year survival was low at 10.6%.
- Combination therapy (preoperative radiotherapy + cystectomy) yielded a >34% 5-year survival for stages B2/C, compared to 17.7% for radiotherapy alone.
Conclusions:
- Bladder squamous cell carcinoma is typically diagnosed at an advanced, invasive stage.
- Combination therapy demonstrates superior survival outcomes for advanced bladder cancer.
- Further clinical trials of combined modality treatment are warranted.